A detailed history of Korea Investment Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Korea Investment Corp holds 1,883,292 shares of JNJ stock, worth $292 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
1,883,292
Previous 1,763,959 6.77%
Holding current value
$292 Million
Previous $258 Million 18.38%
% of portfolio
0.74%
Previous 0.66%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$145.48 - $167.38 $17.4 Million - $20 Million
119,333 Added 6.77%
1,883,292 $305 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $6.84 Million - $7.47 Million
-47,352 Reduced 2.61%
1,763,959 $258 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $9.39 Million - $9.85 Million
-60,514 Reduced 3.23%
1,811,311 $287 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $4.61 Million - $5.03 Million
-31,689 Reduced 1.66%
1,871,825 $293 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $19.2 Million - $21.5 Million
-123,356 Reduced 6.09%
1,903,514 $296 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $22.9 Million - $24.6 Million
-148,166 Reduced 6.81%
2,026,870 $335 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $8.47 Million - $10.1 Million
56,042 Added 2.64%
2,175,036 $337 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $58 Million - $65.1 Million
-362,190 Reduced 14.6%
2,118,994 $374 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $30.1 Million - $33.5 Million
186,598 Added 8.13%
2,481,184 $405 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $26 Million - $28.8 Million
154,770 Added 7.23%
2,294,586 $407 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $37.2 Million - $42.3 Million
235,515 Added 12.37%
2,139,816 $379 Million
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $55.6 Million - $61.7 Million
356,525 Added 23.03%
1,904,301 $326 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $13.8 Million - $15.4 Million
-85,612 Reduced 5.24%
1,547,776 $250 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $10.1 Million - $10.8 Million
63,103 Added 4.02%
1,633,388 $269 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $26.6 Million - $29.6 Million
173,640 Added 12.43%
1,570,285 $258 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $59.9 Million - $68.8 Million
-436,852 Reduced 23.83%
1,396,645 $220 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $19.7 Million - $21.6 Million
-140,549 Reduced 7.12%
1,833,497 $273 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $14.9 Million - $18 Million
-115,600 Reduced 5.53%
1,974,046 $278 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $2.87 Million - $3.97 Million
-25,800 Reduced 1.22%
2,089,646 $274 Million
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $13.9 Million - $15.9 Million
108,800 Added 5.42%
2,115,446 $309 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $1.77 Million - $1.98 Million
13,949 Added 0.7%
2,006,646 $260 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $131,150 - $144,240
1,000 Added 0.05%
1,992,697 $278 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $16.7 Million - $18.6 Million
133,229 Added 7.17%
1,991,697 $278 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $12,284 - $14,784
100 Added 0.01%
1,858,468 $240 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $18.4 Million - $21.6 Million
-150,993 Reduced 7.51%
1,858,368 $257 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $16.3 Million - $18 Million
-136,500 Reduced 6.36%
2,009,361 $0
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $4.85 Million - $5.74 Million
-38,740 Reduced 1.77%
2,145,861 $275 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $11 Million - $12.1 Million
84,200 Added 4.01%
2,184,601 $305 Million
Q3 2017

Oct 25, 2017

BUY
$129.47 - $135.38 $272 Million - $284 Million
2,100,401
2,100,401 $273 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.